Robert J. Matusik

Vanderbilt University Medical Center — United States

Medicine · Health Sciences

58h-index12.5kcitations268works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(148), Hormonal and reproductive studies(35), Estrogen and related hormone effects(25), Cancer, Lipids, and Metabolism(21), Cancer-related molecular mechanisms research(17)

Publications266 total

TIAM1 drives prostatic branching phenotype and is a potential therapeutic target for benign prostatic hyperplasia
JCI Insight·2025· 1 citedOpen Access
Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2
Science Signaling·2024· 5 citedOpen Access
TIAM1 signaling drives prostatic budding and branching phenotypes and is a potential therapeutic target for BPH
2024Open Access
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance
The Prostate·2024· 15 citedOpen Access
Lysosome‐dependent <scp>FOXA1</scp> ubiquitination contributes to luminal lineage of advanced prostate cancer
Molecular Oncology·2023· 12 citedOpen Access
Data from Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells &lt;i&gt;In Vitro&lt;/i&gt;
2023Open Access
Supplementary Data from Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells &lt;i&gt;In Vitro&lt;/i&gt;
2023Open Access
Data from Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells &lt;i&gt;In Vitro&lt;/i&gt;
2023Open Access
Supplementary Data from Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells &lt;i&gt;In Vitro&lt;/i&gt;
2023Open Access
Supplementary Data from Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells &lt;i&gt;In Vitro&lt;/i&gt;
2023Open Access
Supplementary Data from Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells &lt;i&gt;In Vitro&lt;/i&gt;
2023Open Access
Data from Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis
2023Open Access
Supplementary Figure 4 from Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis
2023Open Access
Data from Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy
2023Open Access
Data from KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis
2023Open Access
Supplementary Figure 6 from Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis
2023Open Access
Supplementary Figure from KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis
2023Open Access
Data from KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis
2023Open Access
Supplementary Figure 2 from Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis
2023Open Access
Supplementary figure 1 from Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Xiuping Yu(9), Patricia Sheppard(7), Siegfried Kasper(7), Scott B. Shappell(7), Janni Mirosevich(6), Janice G. Dodd(6), Simon W. Hayward(6), Neil A. Bhowmick(6), Jeffrey M. Rosen(5), David J. DeGraff(5), Paul S. Rennie(4), Richard Roberts(4), Nan Gao(4), Yongqing Wang(4), Naoya Masumori(4), Marcia L. Wills(4), Hironobu Yamashita(4), Wayne D. Tilley(3), Charles L. Sawyers(3), Nicholas Bruchovsky(3)